Search Results 91-100 of 18673 for amyloidosis
Mayo Clinic and Ultromics developed an AI model for highly accurate screening of cardiac amyloidosis, a rare and progressive heart failure.
Is suspected of having cardiac amyloidosis and is willing to undergo a diagnostic evaluation for cardiac amyloidosis (e.g., echocardiography, CMR, bone avid ...
The purpose of this study is to evaluate the prevalence of amyloidosis in patients undergoing surgical intervention for non-congenital spinal stenosis and ...
In addition, information on the effectiveness of ATTR amyloidosis treatments, including eplontersen, which is a ligand-conjugated antisense oligonucleotide gene ...
Blood-based Biomarkers for Early Disease Detection in Cardiac Amyloidosis · Overview · Participation eligibility · Participating Mayo Clinic locations · More ...
... amyloidosis who had a hematologic response to previous treatment for their amyloidosis (e.g., chemotherapy, autologous stem cell transplant [ASCT]) and have ...
... Amyloidosis in participants with suspected Cardiac Amyloidosis. The imaging test that will be used in this study is a Positron Emission Tomography Computed ...
... amyloidosis to determine feasibility of multi-organ MRE technique, and to perform multi-organ MRE in subjects with AL amyloidosis pre- and post-stem cell ...
Like amyloidosis, there are scores of different types of malignant lymphomas, and it is essential to determine the correct diagnosis to tailor therapy ...
The purpose of this study is to provide expanded access of patisiran to patients with hereditary transthyretin-mediated amyloidosis (hATTR). Participation ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!